Home Ultrasound Developer Pulsenmore Establishes U.S. Operations and Appoints General Manager for North America
RAMAT GAN, Israel, April 7, 2022 /PRNewswire/ -- Home ultrasound developer Pulsenmore Ltd. (TASE: PULS) today announced the appointment of Hagar Spits as General Manager North America, as the company establishes U.S. operations in Boston, Massachusetts.
Hagar Spits joins Pulsenmore from Philips, where she headed Strategy & Engagement for the North America healthcare market. Prior to her most recent role, she led Philips Ultrasound Ventures and established its product roadmap.
The U.S. telehealth market has gained unparalleled momentum over the past years and is expected to reach over $300 billion USD by 2028 (U.S. Telehealth Market Report, 2022-2028, Grand View Research, Jan. 2022). Pulsenmore is well positioned for this market with its novel self-operated ultrasound solution, which, combined with a smartphone, enables pregnant women to self-scan for remote clinical assessment of their healthcare provider. The Pulsenmore solution for prenatal home ultrasound has already been implemented across Israel in partnership with the country's largest HMO, Clalit Health Services.
"I am looking forward to leading a convenience and efficiency revolution in U.S. maternal health by putting families in the center and empowering women to play an active role in the management of their pregnancy from home," Hagar commented. "I was inspired by Pulsenmore's home ultrasound solutions and the incredible opportunity they hold in reducing maternal anxiety and identifying risks earlier, which may ultimately result in improved pregnancy outcomes – especially in underserved communities. It is a privilege to join the Pulsenmore team and build our presence in North America. Pulsenmore has the potential to become the new standard in pregnancy care for women everywhere, and the company is advancing an exciting product roadmap."
"We are thrilled to welcome Hagar Spits to lead Pulsenmore's geographical expansion into North America," added Dr. Elazar Sonnenschein, Founder and CEO of Pulsenmore, from the company offices in Ramat Gan, Israel. "Hagar brings 20 years of healthcare experience across three continents and the right skillset as a seasoned commercial leader. I am confident she will direct our business growth successfully."
Hagar holds a BSc in Biomedical Engineering from Tel Aviv University in Israel, and an MBA from INSEAD in France and Singapore.
About Pulsenmore
Pulsenmore is a world leader in portable ultrasound devices for home use and is the first to enable patients to self-scan for remote clinical assessment. The company was founded in 2014 by its CEO, Dr. Elazar Sonnenschein, and aims to make home ultrasound universally accessible for remote and reliable care.
The flagship product for fetal monitoring is approved for marketing in Europe (CE) and in Israel. In the U.S. it is limited by Federal law to investigational use. Clinical studies in the U.S. are currently underway.
Pulsenmore is traded on the Tel Aviv Stock Exchange (TASE: PULS).
For more information:
Rachel Feldman, Marketing Communications – Pulsenmore
SOURCE PulseNmore
Share this article